English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Biotech leaders respond to FDA’s Operation TrialBlazer clinical trial initiative
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

'Me-too' drugs drive increased spending through higher prescribing, USC study finds
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Study links ancient evolutionary pressures to severe COVID-19 risk
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Analysts say AstraZeneca-Bristol Myers Squibb merger unlikely amid antitrust concerns
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Supernus and Indivior announce merger to form central nervous system-focused company
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Researchers develop AI model to aid low-cost foot health monitoring technologies
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Take a Breath for Life 5K returns to Hamburg Fairgrounds to support lung cancer research
+ Pharmaceuticals
Patient Daily | Aug 3, 2026

Amgen reports cybersecurity breach affecting patient and company data

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation